A comparative analysis of the effectiveness of autologous platelet-rich plasma as a new additive for IVM and IVC
Not Applicable
Recruiting
- Conditions
- Factors influencing health status and contact with health services
- Registration Number
- KCT0008597
- Lead Sponsor
- Maria Fertility Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Among the patient population seeking IVF, patients undergoing immature cycles and patients who have undergone three or more transfers, including previous in vitro fertilization(IVF-ET) cycles and thawed embryo transfer cycles, and have failed to conceive will be recruited.
Exclusion Criteria
1. Patients with uterine adenomyosis.
2. Patients with uterine structural factors such as congenital uterine anomaly.
3. Patients with a history of viral diseases or sexually transmitted diseases, including hepatitis
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Development, pregnancy, and implantation rates of embryos cultured using PRP.
- Secondary Outcome Measures
Name Time Method Age, BMI, AMH, duration of infertility, and endometrial thickness in patients who used PRP.